This report describes the first immunoassay which can detect and quantify simultaneously anti-HMGCR and anti-SRP aAbs in patients with NAM, a recently identified, severe form of inflammatory myopathy with important muscle necrosis/regeneration and little inflammation. The gene discussed is UCN2; the disease is myopathy.